Ticker
ZVRACompany Name
ZEVRA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Free Cash Flow | Free Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -46.53M | -75.02% | $ 62.02M |
3/31/2025 | $ -61.82M | -152.31% | $ 40.59M |
12/31/2024 | $ -69.67M | -295.04% | $ 23.61M |
9/30/2024 | $ -69.64M | -280.99% | $ 24.79M |
6/30/2024 | $ -56.3M | -234.74% | $ 23.99M |
3/31/2024 | $ -45.92M | -163.97% | $ 28.01M |
12/31/2023 | $ -33.83M | -123.2% | $ 27.46M |
9/30/2023 | $ -22.1M | -133.41% | $ 16.56M |
6/30/2023 | $ -23.92M | -144.62% | $ 16.54M |
3/31/2023 | $ -19.38M | -206.82% | $ 9.37M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / Revenues
(=) FCF %
FCF % for ZEVRA THERAPEUTICS INC is calculated as follows: FCF [ $ -3.99M ] / Revenues [ $ 12.3M ]
(=) FCF % [ -32.44% ]
Minimum
Dec 31, 2024
Maximum
Mar 31, 2022
Average
Median
filtered constituents | 3.18K |
---|---|
min | -58.23% |
max | 68.19% |
average | 7.85% |
median | 7.37% |
std | 19.48% |